Evidence map›Paper›PMID 24325609›Full record

Trial reportJournal of clinical hypertension (Greenwich, Conn.)2014

Visit-to-visit blood pressure variability and cardiovascular death in the Systolic Hypertension in the Elderly Program.

John B Kostis, Jeanine E Sedjro, Javier Cabrera, Nora M Cosgrove, John S Pantazopoulos, William J Kostis, Sara L Pressel, Barry R Davis

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of clinical hypertension (Greenwich, Conn.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Review
  9. The relationship between day-to-day variability in home blood pressure measurement and multiple organ function.Hypertension research : official journal of the Japanese Society of Hypertension · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Review
  15. Visit-to-Visit Variability of BP and CKD Outcomes: Results from the ALLHAT.Clinical journal of the American Society of Nephrology : CJASN · 2016
    Observational
  16. Review
  17. Review
  18. Visit-to-visit blood pressure variability: more to come.Journal of clinical hypertension (Greenwich, Conn.) · 2015
    Article
  19. Understanding visit-to-visit blood pressure variability.Journal of clinical hypertension (Greenwich, Conn.) · 2014
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

John B KostisCardiovascular Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ.
Jeanine E Sedjro
Javier Cabrera
Nora M Cosgrove
John S Pantazopoulos
William J Kostis
Sara L Pressel
Barry R Davis
Rutgers, The State University of New Jersey · USThe University of Texas Health Science Center at Houston · USEnvironmental and Occupational Health Sciences Institute · USHarvard University · USJohnson University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most studies of an association of visit-to-visit variability of blood pressure with increased risk of future adverse cardiovascular events are of short duration and rarely include a placebo group. Using data from the double-blind, placebo-controlled Systolic Hypertension in the Elderly Program, the authors examined mortality from cardiovascular causes up to 17 years of follow-up using the National Death Index. Visit-to-visit blood pressure variability was associated with cardiovascular death after adjustment for sex, age, serum creatinine, diabetes, body mass index, smoking status, left ventricular failure, and high-density lipoprotein cholesterol. The relationship was significantly stronger in the active treatment group compared with the placebo group. Although this could be the result of an effect of the medications used unrelated to visit-to-visit variability, the data are compatible with the hypothesis that inconsistent adherence leading to missing active medication doses may be an additional explanation for the relationship of visit-to-visit variability with cardiovascular death.

Indexed as

AgedAge FactorsAntihypertensive AgentsAtenololBlood PressureCardiovascular DiseasesChlorthalidoneDose-Response Relationship, DrugDouble-Blind MethodFemaleFollow-Up StudiesHumansHypertensionLongitudinal StudiesMaleOffice VisitsAntihypertensive AgentsAtenololChlorthalidone

Identifiers

PMID24325609
PMCPMC8031777
OpenAlexW1973987932

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.